Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Tables)

12 Months Ended

Dec. 31, 2023

Disclosure of supplementary information to the statements of profit and lost and other comprehensive loss [Abstract]

Schedule of geographical information

	Year ended December 31
	2023		2022		2021
USA (see also Note 18a, 18b, 18c)		13,078		21,872		18,102
EU and other international markets		5,608		4,624		5,661
		18,686		26,496		23,763

Schedule of cost of revenues products

	Year ended December 31
	2023			2022			2021
Salary and benefits (including share-based compensation)		2,703			1,828			2,047
Subcontractors		230			58			190
Depreciation and amortization		672			426			559
Cost of materials		916			636			1,039
Other manufacturing expenses		1,207			779			906
Decrease (increase) in inventory of finished products		(801	)		(543	)		242
		4,927			3,184			4,983

Schedule of cost of revenues services

	Year ended December 31
	2023		2022		2021
Salary and benefits		1,995		1,691		2,003
Subcontractors		8,182		8,138		7,904
		10,177		9,829		9,907

Schedule of cost of revenues license

	Year ended December 31
	2023		2022		2021
Salary and benefits		4		38		102
Royalties payments		-		280		-
		4		318		102
Total Cost of Revenues		15,108		13,331		14,992

Schedule of research expenses

	Year ended December 31
	2023		2022		2021
Salary and benefits (including share-based compensation) (1)		3,148		4,494		2,864
Subcontractors		2,833		4,054		6,323
Depreciation and amortization		396		571		396
Cost of materials		785		572		347
Other research and development expenses		305		490		326
Total Research and development		7,467		10,181		10,256

Schedule of selling expenses

	Year ended December 31
	2023		2022		2021
Salary and benefits (including share-based compensation)		1,991		1,637		1,643
Marketing and consulting		1,637		1,152		627
Depreciation and amortization		50		49		44
Shipping and delivery		356		385		490
Registration and marketing license fees		810		502		584
		4,844		3,725		3,388

Schedule of general expenses

	Year ended December 31
	2023		2022		2021
Salary and benefits (including share‑based compensation)		3,521		3,344		2,905
Professional fees		2,189		2,589		2,480
Depreciation and amortization		185		225		239
Other		873		762		724
		6,768		6,920		6,348

Schedule of financial expense

	Year ended December 31
	2023		2022			2021
Financial income:
Interest income		2,341		270			11
Revaluation of liabilities in respect of IIA grants		-		132			-
Revaluation of Warrants		8,310		-			-
Exchange differences, net		-		59			-
		10,651		461			11
Financial expense:
Revaluation of liabilities in respect of IIA grants		427		-			903
Financing income on net investment in lease		274		102			120
Finance expenses in respect of deferred revenues		8		54			143
Revaluation of liabilities in respect of TEVA		468		533			590
Exchange differences, net		654		-			511
Revaluation of Warrants		-		8,977			-
Issuance expenses of warrants through profit and loss		-		1,911			-
Other		61		60			47
		1,892		11,637			2,314
Financial income (expenses), net		8,759		(11,176	)		(2,303	)